Targeting isocitrate dehydrogenase-1 (IDH1) and IDH2 mutations. Clinical results in advanced hematologic malignancies

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Targeting cancer metabolic dysfunction
Topics Anticancer agents
Clinical research
Haematological Malignancies
Basic Scientific Principles
Therapy
Biological Therapy
Presenter Stephane de Botton